AAOA Launches Pharmacy Toolkit /news/2018-09-18-aaoa-launches-pharmacy-toolkit Allied Against Opioid Abuse (AAOA), a national initiative to help prevent prescription opioid abuse and misuse through education, has created a pharmacy toolkit (http://bit.ly/2xiNmnj) to equip pharmacists with resources to engage and educate patients about the safe use, storage and disposal of pain medicines.
Fact Check: Where 60 Minutes Got it Wrong /news/2019-06-30-fact-check-where-60-minutes-got-it-wrong 60 Minutes has consistently presented misleading, inaccurate accounts of pharmaceutical distributors’ role in the opioid abuse crisis. The latest episode perpetuates a number of myths around the opioid epidemic and does a disservice to any effort to truly understand and address its root causes — notably, the shift in medical practice to treat pain more aggressively and the role of illegal drugs in most overdose deaths.
Americares Honors Endo with Power of Partnership Award /news/2017-06-12-americares-honors-endo-with-power-of-partnership-award Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership award to Endo Pharmaceuticals Inc. and Par Pharmaceutical, operating companies of Endo International plc, in recognition of their outstanding commitment to increasing access to health care around the world. Endo is among Americares most dedicated and longstanding supporters, providing pharmaceutical products for the global relief and development organization’s emergency response work and ongoing health programs.
The Rest of the Story: Facts About Pharmaceutical Distributors and the Opioid Crisis /news/facts-about-rx-distributors-and-the-opioid-crisis As the country continues to face a serious problem with opioid addiction, elected officials, the media and the public continue to discuss and debate the cause and possible solutions to this problem. Unfortunately, these conversations often include a narrow, distorted view of the prescription drug supply chain and, in many cases, overstate pharmaceutical wholesale distributors’ role in this serious public health issue. Many stakeholders in the supply chain — including physicians, pharmacists, manufacturers, distributors, federal and state regulators, law enforcement, and others — share responsibility for opioid abuse and misuse in our country. It is important to understand the role each stakeholder plays as we work to end the current opioid epidemic.
AmeriCares Honors Bristol-Myers Squibb with Power of Partnership Award /news/2015-06-08-americares-honors-bristol-myers-squibb AmeriCares, in partnership with the Healthcare Distribution Management Association (HDMA), has presented its annual Power of Partnership Award to Bristol-Myers Squibb in recognition of its outstanding commitment to increasing access to medicine, health worker safety and improving the wellbeing of children worldwide. Bristol-Myers Squibb and the Bristol-Myers Squibb Foundation are among AmeriCares most consistent supporters, providing both pharmaceutical products and financial support for the aid organization’s emergency response work and ongoing health programs in under-resourced communities.
AAOA Celebrates First Year /news/2019-02-13-aaoa-celebrates-first-year This month marks one year since the launch of Allied Against Opioid Abuse (AAOA), a national initiative to help address the nation’s prescription opioid abuse epidemic through education and awareness. In its first year, AAOA built a network of national and local partnerships, expanding its membership to include 16 national partners and more than 50 state and local partners.
HDA Statement to 60 Minutes /news/2018-12-14-hda-statement-to-60-minutes “While HDA cannot speak to the specifics of the litigation, it defies common sense to single out distributors for the opioid crisis. As logistics experts, distributors do not manufacture, promote or prescribe opioids, influence clinical decision-making or in any way drive demand for the product. Distributors deliver medicines prescribed by a licensed physician and ordered by a licensed pharmacy.
/news/2015-02-02-physicians-offices-and-clinics-are-largest-specialty-rx-customer Physician’s offices and independently owned and operated physician clinics remain the largest customer base for specialty pharmaceutical distributors, at 63 percent of their sales value, according to the 2014 Specialty Pharmaceutical Distribution: Facts, Figures and Trends, published by HDMA’s Center for Healthcare Supply Chain Research.
HDA "Origin" Repository Officially Launches /news/2017-07-31-hda-origin-officially-launches The Healthcare Distribution Alliance (HDA), in collaboration with ValueCentric, LLC, today announce the official launch of Origin: HDA’s Product Data Source. Origin is a high-powered, central data repository hosting verified Global Trade Item Number (GTIN) information. The service enables the secure, accurate and efficient exchange of pharmaceutical product master data between manufacturers and their supply chain partners to help comply with the Drug Supply Chain Security Act (DSCSA).
HDMA Comments on Release of Medicaid AMP Final Rule /news/2016-01-28-amp-statement HDMA President and CEO John M. Gray issued a statement on the Centers for Medicare & Medicaid Services’ (CMS) final rule implementing Affordable Care Act changes to Medicaid rebates, the Average Manufacturer Price (AMP) and Federal Upper Limits under the Medicaid Covered Outpatient Drug Program. The rule, referred to as the “AMP rule,” will go into effect on April 1, 2016, with state Medicaid agencies receiving an additional year to adapt their respective programs to the regulation.
HDMA-Championed Bill S. 483 Passed Unanimously by the Senate /news/2016-03-17-s-483-passes-in-senate HDMA-championed legislation, the Ensuring Patient Access and Effective Drug Enforcement Act (S. 483) was passed today under unanimous consent by the U.S. Senate. The legislation, sponsored by Senators Orrin Hatch (R-Utah) and Sheldon Whitehouse (D-R.I.), has companion legislation (H.R. 471) in the House of Representatives sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.) Peter Welch (D-Vt.) and Judy Chu (D-Calif.). H.R. 471 was passed by the House of Representatives in April 2015.
HDMA to Host Third Annual International Pharmaceutical Distribution Conference in London /news/2016-03-02-hdma-to-host-third-annual-ipdc-in-london The Healthcare Distribution Management Association (HDMA), the U.S.-based trade association representing primary pharmaceutical distributors, announced today that it will convene its Third Annual International Pharmaceutical Distribution Conference (IPDC) in London, England, on September 12-13, 2016, at the Grosvenor House, A JW Marriott Hotel. This year’s conference will be co-hosted with the Healthcare Distribution Association UK (HDA UK), European Healthcare Distribution Association (GIRP) and the International Federation of Pharmaceutical Wholesalers (IFPW). The IPDC was previously held in Beijing and Brussels.
Prescribing Patterns and the Opioid Epidemic /news/prescribing-patterns-and-the-opioid-epidemic While the factors driving the opioid epidemic are complex, there is broad recognition among leading public health authorities that opioids have been overprescribed — a trend that began in the 1990s and continues to this day. As the broader healthcare industry looks to reverse and prevent another epidemic in the future, there is greater focus on how to effectively curb overprescribing while balancing the legitimate and diverse health needs of patients across the country.
/news/2018-01-08-hda-president-and-ceo-outlines-2018-alliance-priorities Efforts to mitigate the prescription drug abuse epidemic and activities surrounding DSCSA implementation once again top the list of priorities HDA will be addressing in the year ahead, according to HDA President and CEO John M. Gray. Mr. Gray provided his perspective, along with other healthcare supply chain leaders, as part of Chain Drug Review’s annual “Pharmacy Outlook” feature, published in the January 1 issue.
HDA Files Lawsuit to Block New York Opioid Law /news/2018-07-06-hda-files-lawsuit-to-block-new-york-opioid-law Today, the Healthcare Distribution Alliance (HDA), the national trade association for pharmaceutical distributors, filed suit in the U.S. District Court for the Southern District of New York to block enforcement of New York’s Opioid Stewardship Act. The act imposes an unconstitutional $600 million punitive surcharge on pharmaceutical distributors and manufacturers. It bypasses judicial due process and impedes the industry’s comprehensive efforts to mitigate opioid abuse and misuse.
Medline Industries //www.hda.org/member-spotlight/medline-industries Medline is a manufacturer and distributor serving the healthcare industry with pharmaceuticals, medical supplies, and clinical solutions that help customers achieve both clinical and financial success. Headquartered in Northfield, Ill., the company offers medical products and pharmaceuticals through direct sales representatives who are dedicated points of contact for customers across the continuum of care.
Associated Pharmacies //www.hda.org/member-spotlight/associated-pharmacies Associated Pharmacies, Inc. (API), the warehouse subsidiary of American Associated Pharmacies (AAP), is designed to lower operating costs and increase margins on Brand Rx, Generic Rx, and OTC’s. API is member-owned, which means the profits make their way back to retail independent pharmacy. Click her for more information.
Quality Care Products //www.hda.org/member-spotlight/quality-care-products QCP is a national distributor of generic drugs, injectable, vaccines, OTC, medical supplies, and Rx/OTC repackaging in low, unit-of-use products in an FDA- and DEA-compliant, secure, state-of-the-art CGMP manufacturing facility. QCP is a primary supplier to 2,546 national healthcare facilities, including retail pharma, dispensing physicians, urgent care, LTC, mail order and surgical centers, as well as institutional and government entities.
Testimony //www.hda.org/news/testimony As part of its advocacy efforts, HDMA is regularly asked to testify on Capitol Hill and in statehouses on issues of importance to primary pharmaceutical distributors.
Executive Committee //www.hda.org/about/executive-committee The Executive Committee consists of the members of the Board of Directors representing each distributor member at the capped dues level, and an equal number plus one of the Board members representing distributor members not at the capped dues level, as selected by the Board. Among the members of the Executive Committee is a chairperson and a vice-chairperson.
Issues in Distribution //www.hda.org/issues HDA reviews key priority issues and advocates on behalf of its pharmaceutical distributor members for standards, public policies and business processes that ensure a safe and efficient supply chain.
Grassroots Advocacy //www.hda.org/issues/grassroots-advocacy HDA member companies' involvement in advocacy and legislative outreach is important to supporting, protecting and promoting the pharmaceutical distribution industry. As an organization that fosters productive partnerships between supply chain stakeholders and lawmakers, HDA facilitates this outreach by encouraging grassroots member participation in the legislative process.
Distributor Licensure //www.hda.org/issues/distributor-licensure The introduction of counterfeit or adulterated medicines into the supply chain is a serious issue that could adversely affect the safety of prescription medicines and the health of patients. To that end, HDA strongly supports tough, rigorous and consistent standards for state licensing of pharmaceutical distributors as required under federal law.
Taxes //www.hda.org/issues/taxes HDA opposes repeal of the Last in, First Out (LIFO) accounting method and establishment of gross receipts taxes. Healthcare distribution represents a high-volume, low-profit margin business that is impacted disproportionately under certain tax proposals, including repeal of LIFO and instituting gross receipts taxes.
Mobile App //www.hda.org/mobile HDA’s mobile app is an essential event resource. After installing the app, select the meeting you are attending from the “Events” menu and log in using the password you normally use to log into HDA’s website to gain instant access to information on the go. Event features include an attendee list, daily schedule, hotel floor plan and more. Additionally, access basic information about HDA, including staff contacts and a link to @HDAconnect on Twitter.
Antitrust Policy //www.hda.org/antitrust It is the unqualified policy of HDA and all of its operating committees to conduct their operations in strict compliance with the antitrust laws of the United States.
Research Foundation //www.hda.org/foundation The HDA Research Foundation is a 501(c)(3) non-profit organization. Founded in 1980, the organization has undertaken projects that fulfill the charitable, research and education priorities of the healthcare supply chain.
Pharmaceutical Sales Through Distributors Reach $493 Billion /news/2019-12-06-hda-foundation-releases-new-factbook In 2018, sales through pharmaceutical distributors increased by 6.7 percent, reaching $492.54 billion, according to a new report by the HDA Research Foundation. The 90th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2019–2020) also notes that chain drug stores were the largest customer base for pharmaceutical wholesalers — accounting for 44.6 percent of all sales, a slight increase from 2017. Distributor margins, however, continued a four-year slide though they showed increases in efficiency.
2020 BLC Online //www.hda.org/events/2020-blc-online The 2020 Business and Leadership Conference has been moved to an online format. Building on the strong attributes associated with our annual member conference, the HDA BLC Online will provide an opportunity to connect with your supply chain partners though a virtual setting.
Speaker Resource Center //www.hda.org/events/speaker-resource-center Congratulations! You have been invited to speak at a Healthcare Distribution Alliance (HDA) event. This resource center provides guidance on the various items HDA needs from you to properly market and promote your session; information about what to expect during the session; and tips for preparing a professional presentation. Please read through this information carefully.
2020 HDA PCSC Online Seminar //www.hda.org/events/2020-hda-pcsc-educational-seminar HDA's 2020 Pharmaceutical Cargo Security Coalition (PCSC) Educational Seminar will now take place virtually. The Pharmaceutical Cargo Security Coalition (PCSC) Online Seminar will bring together those within healthcare, as well as many other industries, that ship and store sensitive, high-risk/high-value products — anywhere in the world.
DSCSA Overview for Dispensers /resources/webinar-dscsa-overview-for-dispensers This webinar, designed for the dispenser audience ― including pharmacy, hospitals, healthcare providers and others who dispense prescription pharmaceuticals ― provides an overview of the Drug Supply Chain Security Act (DSCSA), which paved the way for a single, federal framework to trace prescription medications through the supply chain.
Change Leadership /resources/webinar-change-leadership Leading large-scale change is one of the most difficult challenges we will face during our careers. The most sought-after leaders know how to implement complex change in a way that achieves expected benefits and is grounded in respect for people. Additionally, the leadership actions that lead to successful change, whether small adjustments or enterprise transformation, are specific and repeatable. In this webinar, learn how to differentiate yourself and raise your level of influence through successful change leadership.
/resources/webinar-simplifying-your-master-data-workflow-with-hda-origin (Webinar Held: November 28, 2018) The clock is ticking — and all Rx products packaged after November 27, 2019, will be serialized with GTINs printed on the packaging. In preparing for this deadline companies have been focused not only on the physical packages, but also the data that need to be communicated. To have serialized packages scanned and understood downstream, trading partners need master data.
Origin: HDA's Product Data Source /resources/webinar-origin-hdas-product-data-source HDA’s Origin is an easy-to-use central data repository that will ensure the efficient and accurate exchange of pharmaceutical product master data between manufacturers and their supply chain partners. The repository stores Global Trade Item Numbers (GTINs), the critical product identifier that links a product with its master data to provide a foundation for the industry to initiate using the product identifier required by the Drug Supply Chain Security Act (DSCSA).
"GTIN 101" with GS1 and HDA /resources/webinar-gtin-101-with-gs1-and-hda This webinar, sponsored by Axway, introduces the Global Trade Item Number™ (GTIN®), and how to use this standard to uniquely identify your products in the pharmaceutical supply chain. GS1 US covers how to get a licensed GS1 company prefix, GTIN allocation, assigning indicator digits and how to build a product hierarchy. Participants then hear from a wholesale distributor on the importance of getting GTINs right and common mistakes currently seen today.
Webinar: Leveraging EDI /resources/webinar-leveraging-edi Using EDI to accurately and efficiently exchange business transactions (i.e., purchase orders, acknowledgements, ship notices, invoices, etc.) between distributors and manufacturers in the healthcare supply chain is critical. The development and use of voluntary guidelines for specific EDI standards provide industry trading partners with a means to effectively convey the necessary information.
Webinar: Leveraging Returns Data /resources/webinar-leveraging-returns-data As the use of electronic data interchange (EDI) standards has grown in recent years in forward logistics, companies have looked to leverage these transactions in reverse logistics. The exchange of electronic returns data can streamline the handling process and reduce the cycle time involved in processing returns.
2020 Traceability Online Seminar //www.hda.org/events/2020-traceability-seminar HDA's 2020 Traceability Seminar will now take place virtually. Implementation of the Drug Supply Chain Security Act (DSCSA) continues to transform the pharmaceutical supply chain. HDA’s annual Traceability Seminar brings together healthcare supply chain leaders to learn more about upcoming DSCSA implementation milestones — as well as innovative approaches and lessons learned — as distributors, manufacturers and dispensers implement serialization and traceability technologies to further preserve the safety and security of the healthcare supply chain.
Professional Development //www.hda.org/professional-development Convene: HDA’s Professional Development Program brings together supply chain executives and future leaders to create the next generation of distribution leaders, discuss unique experiences and share tips and tools for developing your career as an industry professional.
Mentoring Program //www.hda.org/professional-development/mentoring Since 2014, HDA's Mentoring Program has established professional relationships for more than 100 men and women, at all stages of their careers. Open to HDA members, the program pairs manufacturers with distributors or third-party service provider professionals to avoid conflicts of interest.
Living at Work /resources/webinar-living-at-work (Webinar held: November 10, 2020) With the lines between work and life blurred during the pandemic, this professional development webinar explores how to strike a better balance during this uncertain time.
Drug Product Availability //www.hda.org/issues/drug-shortages Drug shortages have challenged regulatory and supply chain stakeholders alike in recent years. While there are many factors that may result in a product being in short supply, HDA pharmaceutical distributor members play a central role in exchanging and coordinating information when a shortage occurs.
Careers //www.hda.org/about/careers HDA proudly supports a positive working environment for our staff that allows each individual (and department) to deliver high-quality services to our members, which represent the vital link between the nation’s pharmaceutical manufacturers, pharmacies, hospitals and other providers.
2021 Business and Leadership Conference //www.hda.org/events/2021-business-and-leadership-conference HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
2021 Traceability Seminar //www.hda.org/events/2021-traceability-seminar Implementation of the Drug Supply Chain Security Act (DSCSA) continues to transform the pharmaceutical supply chain. HDA’s annual Traceability Seminar brings together healthcare supply chain leaders to learn more about upcoming DSCSA implementation milestones — as well as innovative approaches and lessons learned — as distributors, manufacturers and dispensers implement serialization and traceability technologies to further preserve the safety and security of the healthcare supply chain.
News /news Read press releases, public testimony and executive statements about HDA's efforts on behalf of pharmaceutical distributors and the entire supply chain.
Michael Leiter /persons/michael-leiter Michael E. Leiter served as the director of the National Counterterrorism Center until July 2011, and is a National Security and Counterterrorism Analyst for NBC News.
Scott Emerson /persons/scott-emerson Scott Emerson has over 30 years of experience with CPG companies and is the founder of The Emerson Group, a forward-thinking consumer products equity organization singularly focused on helping brands reach their maximum potential.
Lisa Scholz /persons/lisa-scholz Lisa Scholz joins Sentry as SVP of Market Strategy after three years as COO and SVP at 340B Health (formerly Safety Net Hospitals for Pharmaceutical Access, or SNHPA).
Mick Ebeling /persons/mick-ebeling Mick Ebeling is a film/television/commercial producer, philanthropist, technology trailblazer, author, entrepreneur and public speaker, and is the CEO of Not Impossible Labs, whose mission is to develop creative solutions to address real-world problems.
Kay Morgan /persons/kay-morgan Kay Morgan is the Senior Vice President of Drug Products and Industry Standards Research and Compliance for Elsevier/Gold Standard. Kay’s responsibilities include product content for Elsevier/Gold Standard products and reviewing existing and new Elsevier/Gold Standard products for compliance with industry standards.
Jon Andresen /persons/jon-andresen Jon Andresen is the President and Principal Consultant of Technology Solutions, an international aviation consultancy focusing on business and technology integration including Spec 2000 eBusiness, UID, RFID, bar coded part marking, part traceability, reliability, and data lifecycle. Clients include the US Dept. of Defense, Boeing, Boeing Helicopter, Bombardier, Honeywell, Fujitsu, Northrop Grumman and other major corporations.
Joshua Bolin /persons/joshua-bolin Josh Bolin is the Membership Relations and Government Affairs Director for the National Association of Boards of Pharmacy (NABP), an international organization whose membership includes every state board of pharmacy in the United States and state or provincial pharmacy regulating agencies in Canada, Australia, New Zealand and South Africa. Bolin joined NABP in late 2005
Julie Kuhn /persons/julie-kuhn Julie Kuhn is Vice President Supply Chain Integrity at H. D. Smith. Julie has more than 20 years of distribution experience, with over 10 years in pharmaceutical distribution
Frank Lee /persons/frank-lee Frank Lee is Vice President, Strategic Development and Support with Smith Drug Company and is tasked with facilitating and guiding the analysis, plan development and implementation of a number of Smith's strategic initiatives.
Charlie Cook /persons/charlie-cook Charlie Cook is Washington’s most trusted and most accurate voice on all things political. As the editor and publisher of The Cook Political Report, his prodigious writing is a direct line to the heart of politics.
Fred Fieder /persons/fred-fieder In his current role, Fred Fieder is primarily responsible for Manufacturer Services across McKesson Financial Center in Carrollton, Texas.
Dina Barton /persons/dina-barton Dina Barton is the Director of Contracts Administration. During her 16-year tenure at AmerisourceBergen, she has held various managerial positions within the Contracts and Chargebacks area.
Kimberly Mazza /persons/kimberly-mazza Kim Mazza is a Senior Consultant in Operations Technology at Cardinal Health with the responsibility of developing and implementing the DSCSA requirements for the Pharmaceutical Distribution operations teams.
Andrew Wilson /persons/andrew-wilson Andrew Wilson is Vice President for 340B Solutions with McKesson and is responsible for guiding and coordinating McKesson 340B strategy and business oversight.
Melissa Laber /persons/melissa-laber Melissa Laber is Senior Vice President, Global Sourcing for National Brands, and leads a team with responsibility for negotiation and management of branded fee-for-service agreements.
JoAnn Gaio /persons/joann-gaio JoAnn Gaio has held a variety of Sales and Management positions at Upsher-Smith Laboratories, Inc. since joining them in 2001, both on the pharmaceutical side of the business, as well as with the Consumer Products business.
Todd Hutsko /persons/todd-hutsko Todd Hutsko serves as Vice President of Sales for Fleet Laboratories responsible for Fleet’s North American business, where he is directly responsible for the consumer sales function that includes Customer Strategy, Shopper Marketing and Sales Operations.
Adrian Bailey /persons/adrian-bailey As a Healthcare Industry Engagement Consultant for GS1 US, Adrian Bailey is responsible for supporting GS1 US healthcare companies, both pharmaceutical and medical device.
Ryan Kelly /persons/ryan-kelly Ryan Kelly is a Senior Manager in the Advisory Services practice of Ernst & Young LLP. He serves as a Serialization and Track-and-Trace Lead for the EY advisory practice and has 10 years of experience across pharmaceutical packaging distribution, mergers & acquisitions and business technology implementation.
Martha Torres-Morgan /persons/martha-torres-morgan Martha Torres-Morgan is the Vice President, Brand Program Management and has responsibility for providing strategic direction for critical new company-wide initiatives in Diabetic, Flu/Core Vaccine and Prescription Vials businesses, as well as to create opportunities and grow business across the Retail and Hospital customer segments.
Vincent Kosewski /persons/vincent-kosewski As Vice President, Supply Chain Operations at Sunovion Pharmaceuticals Inc., Vincent is responsible for contract manufacturing operations, production planning, technical services, warehousing and distribution.
Sean Spears /persons/sean-spears Sean Spears serves as the Senior Director of Trade and Pharmacy Relations and is responsible for business to business interactions with Eisai’s Direct Wholesale and Specialty Distributors along with downstream retail pharmacies and chains.
Keith Vance /persons/keith-vance Keith is the owner and pharmacist manager of Lewisville Drug Company, a Mutual Drug independent pharmacy located in Lewisville, N.C.
Brad Hood /persons/brad-hood Brad Hood is currently the Traceability Coordinator at H. D. Smith and has 15 years of experience in the Logistics and Supply Chain industry.
Chuck Biss /persons/chuck-biss Chuck Biss is Senior Director, AIDC Healthcare at GS1. Active in the AIDC industry since 1973, he has focused on bar code, image analysis, scanning, verification and standards development, along with technical support as well as training and education.
James Stavridis /persons/james-stavridis A highly decorated Navy admiral and the longest-serving global combatant commander in recent American military history, James Stavridis is a “Renaissance Admiral” according to The New York Times.
Nate Taninecz /persons/nathan-taninecz Since joining Product Management in 2011, Nate's focus has been on leading the design of new products and features for the Revenue Management Cloud Commercial Applications suite.
Kathleen Kulp /persons/kathleen-kulp Kathleen Kulp is a Senior Principal with the Managed Markets Services practice of IMS Health with a focus in the Systems Integration Center of Excellence.
Dave Ulrich /persons/dave-ulrich Dave Ulrich is the QA Director for Distribution and Logistics for AbbVie’s Global Pharmaceutical Operations (GPO) division.
Lisa Gutierrez /persons/lisa-gutierrez Lisa Gutierrez serves as Vice President of Diversity and Inclusion for Cardinal Health and leads the development and deployment of strategies that support a diverse and inclusive culture and programs.
Maryann Nelson /persons/maryann-nelson Maryann Nelson is a Regulatory Manager with Cardinal Health, Inc. responsible for developing strategies to insure supply chain integrity, preventing prescription drug diversion and complying with state and federal legislative requirements.
Ming Chang /persons/ming-chang Ming Chang worked in SAP premium support focusing on the security of SAP solution for six years and recently joined the Cloud Information Security Awareness (CISA) team six months ago.
Erin Estey Hertzog /persons/erin-estey-hertzog
Erin Estey Hertzog is the Director of Health Law and Policy at the Biotechnology Innovation Organization (BIO), where she advocates on behalf of the biopharmaceutical industry on topics related to the Medicare, Medicaid and Public Health Service (340B) programs at both the state and federal levels.
Dianne Pfahl /persons/dianne-pfahl Dianne Pfahl is the Vice President of Industry and Manufacturer Relations at Cardinal Health and has been an employee there for almost 15 years.
Mary Tim Smith /persons/mary-tim-smith Mary Tim (Timi) Smith is the Executive Vice President of R&S Northeast LLC and is responsible for the organization’s financial performance and the executive sponsor of the R&S Traceability Team.
Jason Atlas /persons/jason-atlas Jason Atlas is responsible for educating directors of pharmacy, clinicians, and hospital executives on the value of the 340B program and of Apexus, as the 340B Prime Vendor.
Mike Kozin /persons/mike-kozin Mike Kozin is the Director of Sales, Drug Wholesale and Managed Markets at Reckitt Benckiser and is responsible for a variety of areas including: Drug Wholesale, Managed Care, Institutional Sales and Independent Pharmacy.
Ilona Birenbaum /persons/ilona-birenbaum Ilona Birenbaum is a leadership and organizational consultant/leadership coach with over 20 years of experience and a diverse organizational development background.
Susan Camean /persons/susan-camean Susan Camean is Vice President of Strategic Implementation at H. D. Smith, where she is currently developing a team of high performing future senior leaders.
Chad Snyder /persons/chad-snyder Chad has been with Cardinal for the last three years, and is currently a Supervisor in the Pharmaceutical Chargeback department.
Ted Peterson /persons/ted-peterson Ted Peterson is President of CPG Linkages, LLC, a corporate development firm helping trade associations and their members connect with each other and their retailer and wholesaler customers to identify and execute business growth opportunities.
Roxana Levine /persons/roxana-levine Roxana Levine has been with Innovatix for 10 years and is currently Senior Director, Contract Attachment. She works closely with wholesalers and manufacturers to verify member eligibility and confirm attachment to the Innovatix contract portfolios.
Leslie Sanchez /persons/leslie-sanchez Since 2003, Leslie Sanchez has served as a leader in public opinion research specializing in presidential and statewide elections, as well as the women’s and Hispanic-Latino marketplace.
Scott Sopher /persons/scott-sopher Scott is a Principal and is the Global Supply Chain Service Line Leader for Deloitte and has 30 years of supply chain and manufacturing experience in both consulting and industry.
Jeff Uligian /persons/jeff-uligian Jeff Uligian has been with Genentech for ten years and was responsible for opening the Kentucky Distribution Center in Louisville, Kentucky in 2006. He currently has process responsibility for all U.S. Commercial Distribution for Roche.
John Gilbert /persons/john-gilbert John Gilbert is a Director with the law firm of Hyman, Phelps & McNamara, P.C. and advises clients extensively on legal and regulatory issues concerning controlled substances, prescription drugs, and precursor chemicals.
Debbie Adair /persons/debbie-adair Debbie Adair is the Manager of Operations Support and Traceability at R&S Northeast LLC and is responsible for the implementation of systems and processes to support traceability and serialization.
Larry Sabato /persons/larry-sabato Dr. Larry J. Sabato is the founder and director of the University of Virginia Center for Politics and is also the University Professor of Politics at the University of Virginia.
Chris Reed /persons/chris-reed As Lead, Product Serialization and Traceability, Chris led a cross functional team to bring Johnson & Johnson to Drug Supply Chain Security Act Lot Level compliance.
Quentin Dittman /persons/quentin-dittman Quentin has been with Cardinal Health for eight years and has held roles in corporate medical and pharmaceutical warehouse operations, and as a Lean Six Sigma Black Belt within the Operational Excellence team.
Richard Sieg /persons/richard-sieg Richard joined Inmar as Regulatory Counsel in March 2014, managing legal and regulatory considerations for Inmar’s Healthcare and Supply Chain Networks.
Sue Pifer /persons/sue-pifer Sue Pifer is the Vice President of Compliance for the Retail Industry Leaders Association and currently leads RILA’s Environmental Compliance, Internal Audit and Financial Leadership Counsels.
Dan Schawbel /persons/dan-schawbel Dan Schawbel is a New York Times bestselling author, serial entrepreneur, Fortune 500 consultant, millennial TV personality, global keynote speaker, career and workplace expert and startup advisor.
Sergio Santiviago /persons/sergio-santiviago Sergio is Director of Government Affairs for Express Scripts Holding Company and develops and advocates for its public policy interests before the U.S. Congress and Federal government agencies as a lobbyist.
Scott Bradford /persons/scott-bradford Scott Bradford is owner and principal of Bradford Rx Solutions, a consulting company delivering solutions to assist companies manage the complex and costly reverse distribution processes and implement best practices to significantly improve financial performance.
Robert Brown /persons/rob-brown Rob Brown joined Omnicare in April 2013 as Vice President of Business Development for the Specialty Care Group division.
Vijay Karwal /persons/vijay-karwal Vijay Karway is head of Industrials, Consumer & Healthcare advisory with CIMB following its acquisition of the Asia Pacific advisory and equities businesses of RBS in early 2012
Cameron Hall /persons/cameron-hall Cameron Hall serves as Vice President of Products at ValueCentric, leading the company's Marketing and Product Management divisions
J. Mark Bover /persons/j-mark-bover J.Mark is currently the Director of Category Management with Value Drug Company. He started his career as a clerk in an independent pharmacy when he was in the eighth grade.
D. Linden Barber /persons/d-linden-barber D. Linden Barber is the Director of the DEA Compliance and Litigation Practice Group at Quarles and Brady, LLP, and the Managing Partner of the firm's Indianapolis Office. Since joining Quarles & Brady in 2011, Linden has advised and represented a variety of firms and companies registered with the Drug Enforcement Administration (DEA).
Rosemary Schaab /persons/rosemary-schaab Rosemary Schaab is the Controller and Director of Chargeback Administration. During her 10-year tenure at AmerisourceBergen, Rose has been responsible for establishing the Chargeback Accounting and Reporting Team which provides accurate robust data and metrics to support a culture of continuous improvement.
Kurt Proctor /persons/kurt-proctor Kurt A. Proctor, Ph.D., RPh is the Senior Vice President, Strategic Initiatives with the National Community Pharmacists Association (NCPA).
Stephanie Trunk /persons/stephanie-trunk Stephanie Trunk is a Partner in the Health Law Group at Arent Fox LLP in Washington, D.C. Ms. Trunk counsels pharmaceutical and device manufacturers, distributors and their customers, including pharmacy benefit managers, on regulatory, reimbursement and compliance matters.
Brian Waldman /persons/brian-waldman Brian Waldman concentrates his practice in the area of food and drug law and advertising law, counseling clients primarily on pharmaceutical, medical device, food, dietary supplement and cosmetic issues, with particular emphasis on developing effective strategies for introducing and distributing new products.
Naomi Duvall /persons/naomi-duvall Naomi is Director of Consumer Health at Cardinal Health. In this role, Naomi oversees Category Management, shopper insights and collaboration with manufacturer partners.
Peggy Staver /persons/peggy-staver Peggy Staver is Director of Product Integrity with Pfizer Inc. Her responsibilities include developing and implementing strategies to enhance patient safety and further secure the U.S. pharmaceutical supply chain.
Brian Timple /persons/brian-timple Brian is the Director of Financial Operations at Cardinal Health, leading the Pharmaceutical Distribution Chargebacks and Dropship Invoicing teams.
Morgan White /persons/morgan-white Morgan White is Sr. Director, Business Platforms at Upsher-Smith Laboratories with 20 years of experience leading transformational business process projects including ERP and CRM implementations.
Lucy Deus /persons/lucy-deus Lucy Deus is the Vice President of Product Management at TraceLink, helping drive the vision, design and capabilities for TraceLink’s Life Science Cloud global network application platform.
Lloyd Mager /persons/lloyd-mager Lloyd Mager is the Global Lead for AbbVie’s Traceability program and has 30 years of experience in the pharmaceutical industry.
Lisa Hamlin /persons/lisa-hamlin Lisa Hamlin has been providing IT support for the pharmaceutical industry for the past 20 years, and is currently the IT work stream lead for the Actavis Global Serialization team.
Kristin Fitzgerald /persons/kristin-fitzgerald Kristin Fitzgerald is with U.S. EPA’s Office of Resource Conservation and Recovery in Washington, DC. She has been with the Agency for fourteen years, working primarily on hazardous waste generator issues.
Josh Smeraldi /persons/josh-smeraldi Josh Smeraldi is with U.S. EPA’s Office of Resource Conservation and Recovery and has been with the Agency for 1 year, working primarily on hazardous waste issues.
Connie Jung, RPh, PhD /persons/connie-jung Dr. Jung is currently Acting Associate Director for Policy and Communications in the new Office of Drug Security, Integrity, and Recalls in FDA’s Center for Drug Evaluation and Research, Office of Compliance.
Greg Yonko /persons/greg-yonko Greg Yonko serves as Senior Vice President for Global Sourcing and Purchasing for McKesson Corporation, a $160B, Fortune 15 Global health care company.
Brad Pine /persons/brad-pine Brad Pine is currently the Vice President, Brand/Specialty Rx and Regulatory for Smith Drug Company; he has over 25 years of experience in the pharmaceutical wholesale industry.
Chris Savage /persons/chris-savage Chris Savage is results-driven consumer team leader with extensive industry experience demonstrated through a skill set built on progressive roles of national account management, category leadership, customer marketing and financial analysis.
Patricia Scott /persons/patricia-scott Dr. Patricia Scott is a leader in the field of communication and provides her students and her clients a unique blend of time-tests strategies and real-world application, with more than 15 years of corporate leadership experience.
Mike McBride /persons/michael-mcbride Mike McBride is Vice President, Partner Relations at Upsher-Smith Laboratories and has more than 25 years of experience in the consumer products and pharmaceutical industry.
Peyton Howell /persons/peyton-howell Peyton Howell is Executive Vice President and President, Global Sourcing and Manufacturer Relations for AmerisourceBergen, where she leads manufacturer strategy and sourcing including brand, generic, specialty and consumer product purchasing of nearly $100 Billion.
Rene Jenny /persons/rene-jenny Mr. René Jenny was elected the President of the European Association of Pharmaceutical Full-line Wholesalers (GIRP) in 2005 and has held this position ever since
Scott Mooney /persons/scott-mooney Scott Mooney is Vice President of Distribution Operations at McKesson Corporation. His primary responsibilities are assuring product integrity through regulatory compliance and traceability.
Akin Odutola /persons/akin-odutola Akin Odutola is Vice President, Global Branded Rx Sourcing for AmerisourceBergen Corporation. In his role, Akin and his team manages the sourcing activities for Branded and Specialty pharmaceuticals across the AmerisourceBergen enterprise.
Kathy Lang /persons/kathy-lang Kathy Lang is a Senior Director, Trade Relations at Valeritas, Inc. Her expert knowledge of the pharmaceutical industry, relationships and excellent reputation ensured the successful launch of V-Go® into the diabetes market.
Jim Cline /persons/jim-cline Jim is a member of the Cardinal Health Corporate EHS leadership team with responsibilities for all aspects of environmental, health & safety (EHS) and loss prevention for various Cardinal Health businesses.
Sarah Krueger /persons/sarah-krueger Sarah joined Cardinal Health in 2013 as Category Sourcing Manager of Consumer Health where she is responsible for driving business growth for seven Wellness categories through assortment management, marketing initiatives and product promotion.
Speaker Tips and Guidelines //www.hda.org/events/speaker-resource-center/speaker-tips-and-guidelines Every year, thousands of individuals attend HDA events. In addition to the many networking opportunities available at these meetings, attendees appreciate and expect that the sessions they attend will be well planned and thought-provoking, with significant take-home value. This guide has been compiled to help you plan, prepare and deliver a professional presentation. Even if you are a seasoned speaker or facilitator, we recommend you taking a few moments to review the contents on this page.
Daily Schedule //www.hda.org/events/2019-business-and-leadership-conference/daily-schedule HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Business Appointments //www.hda.org/events/2019-business-and-leadership-conference/business-appointments HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
PartnerLinx //www.hda.org/events/2019-business-and-leadership-conference/business-appointments/partnerlinx HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Benefits //www.hda.org/events/2019-business-and-leadership-conference/service-provider-pavilion/benefits HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Cancellation Policies //www.hda.org/events/2019-business-and-leadership-conference/cancellation-policies HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Sponsorship //www.hda.org/events/2019-business-and-leadership-conference/sponsorship HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Contact Us //www.hda.org/events/2019-business-and-leadership-conference/contact-us HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Contact Us //www.hda.org/events/2020-blc-online/contact-us We are pleased to announce that the 2020 Business and Leadership Conference has been moved to an online format. Building on the strong attributes associated with HDA's annual member conference, the HDA BLC Online will now provide an opportunity to connect with your supply chain partners though a virtual setting.
Contact Us //www.hda.org/events/2020-hda-pcsc-educational-seminar/contact-us HDA's 2020 Pharmaceutical Cargo Security Coalition (PCSC) Educational Seminar will now take place virtually. The Pharmaceutical Cargo Security Coalition (PCSC) Online Seminar will bring together those within healthcare, as well as many other industries, that ship and store sensitive, high-risk/high-value products — anywhere in the world.
How to Participate //www.hda.org/professional-development/mentoring/how-to-participate The level of participation and type of relationship is up to you. Some participants may want to focus on a specific project or aspect of their current jobs; others may want guidance on navigating the industry or preparing for a new role or promotion. Accordingly, some mentor/mentee relationships will be long-term and others will be short-term; some will be structured and others will be more fluid. One size does not fit all!
Service Provider //www.hda.org/about/membership/service-provider HDA service providers provide goods and services to distributors and manufacturers that are not intended for resale. These companies may include, but are not limited to, advertisers and consultants, public relations firms, media companies, brokers, hardware/software suppliers and publishers.
Distributor //www.hda.org/about/membership/distributor Distributors considering an HDA membership must purchase or receive pharmaceutical and health-related products in bulk quantities, inventory these products, distribute them in individual package quantities and provide other value-added services to its suppliers and healthcare providers.
Nominations //www.hda.org/about/industry-recognition/diana/nominations The DIANA Best Overall Manufacturer Award is a distributor-driven nomination process. HDA distributor members are asked to nominate their top five manufacturer partners in each of the categories. The nomination process for the DIANA Best New Product or Promotion Awards is primarily manufacturer-driven, with manufacturer members asked to submit nomination materials in the applicable five categories. HDA distributor members also may nominate a trading partner for the awards.
DMA //www.hda.org/about/industry-recognition/dma The Distribution Management Award honors HDA member companies’ efforts to improve the efficiency, effectiveness and safety of the healthcare supply chain through successful trading partner initiatives that enhance processes, reduce costs and leverage advanced technologies or logistical practices.
Contact Us //www.hda.org/events/2021-business-and-leadership-conference/contact-us HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Hotel and Travel //www.hda.org/events/2021-business-and-leadership-conference/hotel-and-travel HDA’s Business and Leadership Conference (BLC) is the healthcare distribution industry’s signature annual conference, developed by and for healthcare supply chain leaders and innovators. Exclusive to HDA member companies, the conference brings together high-level executives, thought leaders and influential managers from across the healthcare supply chain to hold strategic business discussions on the most pressing industry issues.
Healthcare Distribution: Rain, Snow or Shine //www.hda.org/news/hda-blog/2019/02/01/10/00/2019-02-01-healthcare-distribution-rain-snow-or-shine Pharmaceutical distributors deliver millions of medicines and healthcare products to providers nationwide — rain, snow or shine. Every day, hundreds of thousands of patients across the country depend on the uninterrupted delivery of prescription medicines, and pharmaceutical distributors work around the clock to ensure these products get to where they need to be, safely and efficiently. As winter marches on, with snowstorms and sub-zero temperatures in parts of the country, HDA member companies rise to the challenge of making sure vital medicines reach the people who need them, no matter what it takes.
That's A Great Question //www.hda.org/news/hda-blog/2019/05/16/09/44/2019-05-16-a-great-question Most Americans take for granted the complex pharmaceutical supply chain that ensures their medication arrives safely, reliably and efficiently at the pharmacy, doctor’s office or hospital. Have you ever wondered how pharmacies and healthcare providers keep these vital medicines in stock so that patients have access to medicines when they need them, even during weather emergencies?
More Than Just Delivery //www.hda.org/news/hda-blog/2019/04/25/15/38/2019-04-26-more-than-just-delivery As the logistics experts of healthcare, distributors deliver millions of prescription medicines and healthcare products to hundreds of thousands of providers, including pharmacies, hospitals and healthcare facilities, across the country. But their relationships with these customers is about more than just delivery — distributors offer additional services that allow their customers to focus on patients and remain competitive in the marketplace.
Distributors Leading the Way in the Next Phase of COVID-19 //www.hda.org/news/hda-blog/2020/11/23/13/07/2020-11-23-distributors-leading-the-way Since the emergence of COVID-19, HDA distributor members have worked tirelessly to navigate the exceptional and unprecedented demands of this public health emergency. From managing unique inventory demands of the first hotspots, to ensuring access to emerging treatment options and testing, HDA members draw upon their extensive supply and distribution networks, logistics expertise and experience navigating public health emergencies. Moreover, distributors are committed to the public- and private-sector partnerships that are critical in combating COVID-19, fueling our recovery and improving pandemic resiliency for the future.
Healthcare Distribution Centers //www.hda.org/news/hda-blog/2019/01/25/13/58/2019-01-25-healthcare-distribution-centers Pharmaceutical distributors have a long history of bringing the newest advancements and technologies to their warehouses. Back in 1947, the National Wholesale Druggists’ Association (an early iteration of HDA) tapped Ohio State University marketing experts to reimagine an entirely new type of layout for wholesaler warehouses, which included longer aisles, moving belts, “and roller skates for order pickers.” While the roller skates never caught on, healthcare distributors’ commitment to harnessing innovation to develop facilities that safely and securely get prescription medicines and medical products to the patients who need them has only grown.